Blog

Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts

industry.gov.au

Nov 1, 2024, 11:28

Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts

Sherene Loi, Medical Oncologist, Lab Head of Breast Oncology Clinical Trials at Peter MacCallum Cancer Centre, shared on X:

“Sharing our latest article: Here we show that dose dense AC-T, radiotherapy and age affects long-term lymphocyte counts post adjuvant breast cancer treatment ?implications for IO therapy.”

Sustained lymphocyte decreases after treatment for early breast cancer

Authors: Julia Dixon-Douglas, Balaji Virassamy, Kylie Clarke, Michael Hun, Stephen J. Luen, Peter Savas, Courtney T. van Geelen, Steven David, Prudence A. Francis, Roberto Salgado, Stefan Michiels, Sherene Loi

Sherene Loi

More posts featuring Immunotherapy on oncodaily.com

Balaji Virassamy cancer Courtney T. van Geelen Julia Dixon-Douglas Kylie Clarke Michael Hun OncoDaily Oncology Peter Savas Prudence A. Francis radiotherapy Roberto Salgado Sherene Loi Stefan Michiels Stephen J. Luen Steven David

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage